Condition: Chronic Pancreatitis · Recurrent Acute Pancreatitis · Exocrine Pancreatic Insufficiency · Sponsor: Anna Evans Phillips
This project uses the Malabsorption Blood Test (MBT) to identify patients with recurrent acute or chronic pancreatitis who have mild to moderate exocrine pancreatic insufficiency. A subgroup of patients who have response to pancreatic enzyme replacement therapy will enter a randomized, placebo-controlled pilot clinical trial for 8 weeks to identify improvements in quality of life (QOL).
This description comes directly from the study's public registry record.
Anna E Phillips, MD MS · 412-864-7096 · Evansac3@upmc.edu
Apsara Mishra, BSC · 412-383-2447 · apm179@pitt.edu
Always discuss trial participation with your own doctor first.
| Johns Hopkins Medicine | Baltimore, Maryland, United States | Not Yet Recruiting |
| University of Pittsburgh Medical Center | Pittsburgh, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07418593